Bio-Recovery Inc.July 24, 2018

FDA 483 - Bio-Recovery Inc. - July 24, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bio-Recovery Inc.

Record Details

An FDA inspection of Bio-Recovery Inc., an own label distributor in Minneapolis, MN, revealed significant quality control deficiencies. The firm failed to properly review documentation for quarantined products and did not conduct necessary tests for strength and contamination before releasing dietary supplements. These issues indicate a lack of adherence to established specifications and testing requirements for product release.

Company: Bio-Recovery Inc.
Inspection Date: July 24, 2018
Product Type: Other
Office: Minneapolis District Office
Person: Douglas J. Snyder

Open in Dashboard

ID · 5b235241-2837-4725-acd1-bfc68e053917